Author

Line Srour

Institutions: Université de Sherbrooke, Hôpital Charles-Le Moyne

Observed institutions: BC Cancer Agency, Mayo Clinic, Karolinska University Hospital, Université de Sherbrooke, University of British Columbia, Lund University, Karolinska Institutet, Hôpital Charles-Le Moyne, Skåne University Hospital

OpenAlex ID: A5013370240

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

2020 · Ciara L. Freeman, Kerry J. Savage, et al. · Blood · 90

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma

2017 · Matthew J. Maurer, Fredrik Ellin, et al. · Journal of Clinical Oncology · 72

Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas

2019 · Fredrik Ellin, Matthew J. Maurer, et al. · British Journal of Haematology · 24

Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia

2017 · Ciara Louise Freeman, Kerry J Savage, et al. · Blood · 8

EFS24 as a predictor of outcome in a population-based cohort of patients with DLBCL in British Columbia (BC).

2016 · Line Srour, Yvonne Y. Zheng, et al. · Journal of Clinical Oncology · 4

Patients' perspectives and safety of COVID-19 vaccination among cancer patients: A prospective single-center study.

2022 · Nathalie Daaboul, Melina Boutin, et al. · Journal of Clinical Oncology

An International Assessment of Event-Free Survival at 24 Months (EFS24) and Subsequent Survival in Peripheral T-Cell Lymphoma

2016 · Matthew J Maurer, Fredrik Ellin, et al. · Blood

Works count: 7

Citation count: 198

H-index: 4

I10-index: 3